Why Disease Risk Lives in the Exposome
For 20 years, genomics has promised precision medicine. And it delivered. For rare diseases and select cancers. But for most chronic conditions? Genetics explains only a fraction of risk. Type 2 diabetes. Alzheimer’s disease. Autoimmune disorders. Metabolic syndrome....
Mechanistic Insights into Functional Foods With Metabolomics
The functional foods market has expanded rapidly over the past two decades, driven by consumer interest in products offering health benefits beyond basic nutrition. However, this growth has outpaced the scientific evidence supporting many product claims, creating...
Quantitative Metabolomics for Clinical and Translational Research
The Precious Sample Challenge in Clinical Research Clinical and translational research frequently confronts a fundamental constraint: limited biological sample availability. Pediatric studies, rare disease investigations, longitudinal monitoring protocols, and tissue...